Security key
185053402
Clearmind Medicine Inc. - Common Shares, no par value per share (CMND)
CUSIP: 185053402
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 92,693
- Total 13F value
- $260,467
- Share change
- +92,693
- SEC-reported price per share
- $2.81
- Number of holders
- 1
- Value change
- +$260,467
- Number of buys
- 1
- Shares outstanding
- 2,174,400
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
1
Top holders
1
CMND full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Clearmind Medicine Inc. SEC filings
Clearmind Medicine Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 185053402
Recent filing periods:
Ownership snapshot
Top reported holders of CMND - Clearmind Medicine Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Walleye Capital LLC
Disclosed value leader
Walleye Capital LLC
Comparable rows
0/6
Latest evidence
30 Sep 2023
13F
Highest disclosed value: $61,717
6 rows are not safely comparable across share classes.
Quick read
Walleye Capital LLC has the largest disclosed position value at $61.7K.
0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Walleye Capital LLC's linked filing trail.
Disclosed position value
Top 5
Walleye Capital LLC
$61.7K
Warberg Asset Management LLC
$35.2K
AdvisorShares Investments LLC
$19.7K
GEODE CAPITAL MANAGEMENT, LLC
$10.2K
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Walleye Capital LLC |
13F
Company
|
—
class O/S missing
|
$61,717
385,729 shares
|
— | 30 Sep 2023 |
| Warberg Asset Management LLC |
13F
Company
|
—
class O/S missing
|
$35,200
220,000 shares
|
— | 30 Sep 2023 |
| AdvisorShares Investments LLC |
13F
Company
|
—
class O/S missing
|
$19,721
123,257 shares
|
— | 30 Sep 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$10,170
63,564 shares
|
— | 30 Sep 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
class O/S missing
|
$7,960
49,751 shares
|
— | 30 Sep 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$2,353
14,704 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
92,693
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2025 Across Filers
Q3 2025 holders
7
Q4 2023 holders
1
Holder diff
-6
| Investor | Q3 2025 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend